Methods of treating allergy by administering a CD200 protein
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 29, 2007
Grant Date -
Mar 3, 2005
app pub date -
May 21, 2004
filing date -
Nov 7, 1997
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a CD200 protein or a nucleic acid encoding a CD200 protein. The methods are useful in preventing graft rejection, fetal loss, autoimmune disease, and allergies. Methods and compositions for preventing immune suppression are also disclosed. The methods involve administering an effective amount of an agent that inhibits CD200. Such methods are useful in treating cancer.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully